from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3091/-

LFCtreatmentdescriptionclass of inhibitor

-0.170

Amikacinug/mL Amikacintranslation

0.434

Cap5-10ug/mL Capreomycintranslation

0.986

Rox10-50 ug/mL Roxithromycintranslation

0.264

SM2-5 ug/mL Streptomycintranslation

0.117

Tet5-10 ug/mL Tetracyclinetranslation

0.181

Rif0.2-5ug/mL Rifampicintranscription

0.107

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.958

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.834

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.281

CPZ10-50 ug/mL Chlorpromazinerespiration

1.687

Clofazimine10-13 ug/mL Clofaziminerespiration

0.528

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.820

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.995

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.814

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.285

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.652

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.658

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.104

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.038

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.657

Nigericin50 uM Nigericinrespiration

-0.170

TRC10-150 ug/mL Triclosanrespiration

1.595

TRZ10-25 ug/mL Thioridazinerespiration

-0.625

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.456

menadione6-10 ug/mL Menadionerespiration

-0.743

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.060

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.194

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.518

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.410

NRP_1Non-replicating persistence stage 1dosRassociated

-0.360

Amp0.2mg/mL AmpicillincellWall

0.590

Cephalexin20-100 ug/mL CephalexincellWall

0.277

Cerulenin0.32-5 ug/mL CerulenincellWall

0.401

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.367

EMB10-20 ug/mL EthambutolcellWall

0.114

Eta12-40 ug/mL EthionamidecellWall

0.010

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.229

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.981

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.831

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.579

BZA0.12 mg/mL BenzamidearomaticAmides

-0.246

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.321

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.316

H2O24 mM hydrogen peroxideDNAdamaging

-0.099

Levo10 ug/mL LevofloxacinDNAdamaging

-0.235

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.064

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.400

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.217

UVUV-irradiationDNAdamaging

0.942

ARP41-4 ug/mL Antitubercular compound ARP4?

0.254

Antimycin12.5-50 ug/mL Antimycin A?

-1.110

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.341

PA_110-50 ug/mL Antitubercular compound PA-1?

0.028

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.988

PA8240.2-2 ug/mL PA-824?

0.466

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.804

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.652

Verapamil50 uM Verapamil?

-0.790

mercaptoethanol2 mM 2-Mercaptoethanol?

1.089

methoxatin10-20 ug/mL Methoxatin?